Schacterle Amy, Chief Regulatory Officer at Acumen Pharmaceuticals ($ABOS), sold shares once on the open market in the last 365 days for a total of $2,176. Her most recent sale occurred on January 7, 2026. This places her 11,493rd out of 11,678 insiders by sale value, compared to an average of $8.6 million per insider and about 6.4 transactions. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 16, 2026 | Acumen Pharmaceuticals, Inc. | $ABOS | Schacterle Amy | Chief Regulatory Officer | A | Common Stock | 84600 | $0.00 | 92,303.0000 | 60,573,425 | 1098.27% | 0.14% |
| Jan. 16, 2026 | Acumen Pharmaceuticals, Inc. | $ABOS | Schacterle Amy | Chief Regulatory Officer | A | Employee Stock Option (right to buy) | 126900 | $0.00 | 126,900.0000 | 60,573,425 | 9999.99% | 0.21% |
| Jan. 7, 2026 | Acumen Pharmaceuticals, Inc. | $ABOS | Schacterle Amy | Chief Regulatory Officer | S | Common Stock | 1097 | $1.98 | 7,703.0000 | 60,573,425 | 12.47% | 0.00% |
| Jan. 6, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Schacterle Amy | Chief Regulatory Officer | A | Common Stock | 8800 | $0.00 | 8,800.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Schacterle Amy | Chief Regulatory Officer | A | Employee Stock Option (right to buy) | 13200 | $0.00 | 13,200.0000 | 0 | 9999.99% | 0.00% |
| Nov. 5, 2024 | Acumen Pharmaceuticals, Inc. | $ABOS | Schacterle Amy | Chief Regulatory Officer | A | Employee Stock Option (right to buy) | 340000 | $0.00 | 340,000.0000 | 0 | 9999.99% | 0.00% |